3-[1-(5-Bromofuran-2-carbonyl)piperidin-4-yl]-4-[(4-fluorophenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one

Catalog No. :
ACCZOX239
CAS No. :
1775547-65-3
Molecular Formula :
C19H18BrFN4O3
Molecular Weight :
449.28

IUPAC Name:5-(1-(5-bromofuran-2-carbonyl)piperidin-4-yl)-4-(4-fluorobenzyl)-2,4-dihydro-3H-1,2,4-triazol-3-one

3-[1-(5-Bromofuran-2-carbonyl)piperidin-4-yl]-4-[(4-fluorophenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-[1-(5-Bromofuran-2-carbonyl)piperidin-4-yl]-4-[(4-fluorophenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one
IUPAC Name5-(1-(5-bromofuran-2-carbonyl)piperidin-4-yl)-4-(4-fluorobenzyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
MDL No.MFCD28976336
Molecular FormulaC19H18BrFN4O3
Molecular Weight449.28
SMILESO=C1N(CC2=CC=C(F)C=C2)C(C3CCN(C(C4=CC=C(Br)O4)=O)CC3)=NN1
InChI KeyCUWGHAMPOKWYAZ-UHFFFAOYSA-N
Synonym3-[1-(5-bromofuran-2-carbonyl)piperidin-4-yl]-4-[(4-fluorophenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one;3H-1,2,4-Triazol-3-one, 5-[1-[(5-bromo-2-furanyl)carbonyl]-4-piperidinyl]-4-[(4-fluorophenyl)methyl]-2,4-dihydro-
CAS No.1775547-65-3

Synthetic Route by SureRoute

1. ACCZOX239 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCZOX239 route product structure diagram
    ACCZOX2391775547-65-3
Inquiry

2. ACCZOX239 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLNUT108 route compound structure diagram
    ACLNUT10826726-16-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCZOX239 route product structure diagram
    ACCZOX2391775547-65-3
Inquiry

Comments (0)